NasdaqCM - Delayed Quote USD

Femasys Inc. (FEMY)

1.1500
+0.0100
+(0.88%)
At close: May 8 at 4:00:01 PM EDT
1.1199
-0.03
(-2.62%)
After hours: May 8 at 7:58:46 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Kathy Lee-Sepsick M.B.A. Founder, President, CEO & Director 661.22k -- 1968
Mr. Dov Elefant Chief Financial Officer 548.8k -- 1967
Mr. Daniel Scott Currie COO, Senior VP & Secretary 491.37k -- 1964
Ms. Mary An Merchant J.D., Ph.D. Vice President of Counsel & Intellectual Property -- -- --
Ms. Naomi Phaneuf Vice President of Marketing -- -- --
Mr. Benjamin Dings Vice President of Sales -- -- --
Dr. Jeffrey Marcus M.D., M.S. Chief Medical Advisor -- -- --
Ms. Christine Thomas Senior VP of Regulatory & Clinical Affairs -- -- 1973
Dr. James H. Liu M.D. Chief Medical Officer -- -- --
Mr. Richard Spector Chief Commercial Officer -- -- 1971

Femasys Inc.

3950 Johns Creek Court
Suite 100
Suwanee, GA 30024
United States
770 500 3910 https://www.femasys.com
Sector: 
Healthcare
Full Time Employees: 
69

Description

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Corporate Governance

Femasys Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 28, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 29, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers